Conexeu Sciences director buys shares and warrants
Conexeu Sciences Inc. director and 10% owner Lynn Sebastian Purcell, through OnePointTwo Capital Ventures LLC, reported significant indirect insider activity in common stock and warrants on 2026-06-18.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Conexeu Sciences Inc. director and 10% owner Lynn Sebastian Purcell, through OnePointTwo Capital Ventures LLC, reported significant indirect insider activity in common stock and warrants on 2026-06-18. The LLC bought 202,500 shares of common stock at $0.80 per share, bringing its indirect common stock holdings to 2,734,240 shares. It also exercised warrants for 202,500 underlying common shares at an exercise price of $0.80 and separately bought 202,500 additional warrants at $0.001 per warrant, each exercisable for common stock at $2.30 per share, leaving 625,000 warrants indirectly held.
Insights
Indirect owner increases CNXU exposure via stock and warrant buys.
OnePointTwo Capital Ventures LLC, associated with director and 10% owner Lynn Sebastian Purcell, made a net insider net-buy in Conexeu Sciences on 2026-06-18. It purchased 202,500 common shares at $0.80 and added 202,500 warrants while exercising another 202,500-share warrant position.
This combines an open-market equity purchase with a derivative exercise, raising direct economic exposure to both current shares and future upside via warrants. Following the transactions, the LLC reports 2,734,240 common shares and 625,000 warrants held indirectly, indicating continued alignment with equity performance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Warrant | 202,500 | $0.001 | $202.50 |
| Exercise | Warrant | 202,500 | $0.80 | $162K |
| Purchase | Common Stock | 202,500 | $0.80 | $162K |
Key Figures
Key Terms
open-market purchase financial
derivative exercise/conversion financial
Warrant financial
indirect financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions were reported for CNXU on June 18, 2026?
Who executed the recent Conexeu Sciences (CNXU) insider trades?
What warrant activity did the CNXU insider report on June 18, 2026?
Is the recent Conexeu Sciences (CNXU) Form 4 mainly a buy or a sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.